The National Academies of Sciences, Engineering, and Medicine (National Academies) is convening a three-part workshop series, sponsored by FDA, examining how real-world evidence development and uptake can enhance medical product development and evaluation. The workshops will advance discussions and common knowledge about complex issues relating to the generation and utilization of real-world evidence, including fostering development and implementation of the science and technology of real-world evidence generation and utilization.
• Workshop One (September 19-20, 2017 ) focused on how to align incentives to support collection and use of real-world evidence in health product review, payment, and delivery. Incentives need to address barriers impeding the uptake of real-world evidence, including barriers to transparency.
• Workshop Two (March 6-7, 2018 ) illuminated what types of data are appropriate for what specific purposes and suggested practical approaches for data collection and evidence use by developing and working through example use cases.
• Workshop Three (July 17-18, 2018) will examine and suggest approaches for operationalizing the collection and use of real-world evidence through discussing and revising "decision aids" about specific topics in study design. The decision aids will be question lists to help inform stakeholders about study design choices, including potential risks, costs, and reporting/transparency expectations. 
